Atlas FDA

Juvéderm Injectable Gel Implants

FDA premarket approval P110033/S045 · decided 2019-05-10

Approval details

PMA number
P110033
Supplement
S045
Supplement type
30-Day Notice
Supplement reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Trade name
Juvéderm Injectable Gel Implants
Generic name
Implant, dermal, for aesthetic use
Applicant
Allergan
Date received
2019-04-10
Decision date
2019-05-10
Days to decision
30 days
Decision code
OK30
Product code
LMH
Advisory committee
General, Plastic Surgery
Expedited review
No
Location
Irvine, CA
Statement
Implementation of an additional identical tank used to manufacture high molecular weight hyaluronic acid (HA) at the raw material supplier.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
NATRELLE INSPIRA Single Use Sizers for Gel Implants (K203229)Allergan2021-06-02
TrueTear Intranasal Tear Neurostimulator (K193589)Allergan2020-08-31
Natrelle 133 Plus MICROCELL Tissue Expander (K180826)Allergan2018-12-21
Natrelle 133S Tissue Expander (K182054)Allergan2018-08-29
TrueTear Intranasal Tear Neurostimulator (DEN170086)Allergan2018-05-17
SERI SURGICAL SCAFFOLD (K123128)Allergan2013-04-25